Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy

被引：1
|
作者：
Ben-Ari, Z
Mor, E
Shaharabani, E
Bar-Nathan, N
Shapira, Z
Tur-Kaspa, R
机构：
[1] Rabin Med Ctr, Liver Inst, IL-49100 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Dept Med D, IL-49100 Petah Tiqwa, Israel
[3] Rabin Med Ctr, Dept Transplantat, IL-49100 Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 04期
关键词：
D O I：
10.1016/S0041-1345(00)00951-9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：709 / 710
页数：2
相关论文
共 50 条
  • [1] CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY - A CLINICOPATHOLOGICAL STUDY OF 96 PATIENTS
    DEMETRIS, AJ
    FUNG, JJ
    TODO, S
    MCCAULEY, J
    JAIN, A
    TAKAYA, S
    ALESSIANI, M
    ABUELMAGD, K
    VANTHIEL, DH
    STARZL, TE
    [J]. TRANSPLANTATION, 1992, 53 (05) : 1056 - 1062
  • [2] CONVERSION FROM CYCLOSPORINE TO FK-506 IN LIVER ALLOGRAFT RECIPIENTS WITH CYCLOSPORINE-RELATED COMPLICATIONS
    FUNG, JJ
    TODO, S
    JAIN, A
    MCCAULEY, J
    ALESSIANI, M
    SCOTTI, C
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1990, 22 (01) : 6 - 12
  • [3] CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK 506-BASED IMMUNOSUPPRESSION - BENEFITS AND PITFALLS
    FUNG, JJ
    TODO, S
    TZAKIS, A
    DEMETRIS, A
    JAIN, A
    ABUELMAGD, K
    ALESSIANI, M
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 14 - 21
  • [4] FK506 VERSUS CYCLOSPORINE AS PRIMARY IMMUNOSUPPRESSIVE AGENT FOR ORTHOTOPIC LIVER ALLOGRAFT RECIPIENTS - HISTOLOGIC AND IMMUNOPATHOLOGIC OBSERVATIONS
    HYTIROGLOU, P
    LEE, R
    SHARMA, K
    THEISE, ND
    SCHWARTZ, M
    MILLER, C
    THUNG, SN
    [J]. TRANSPLANTATION, 1993, 56 (06) : 1389 - 1394
  • [5] FK506 HEPATOTOXICITY IN LIVER ALLOGRAFT RECIPIENTS
    FISHER, A
    MOR, E
    HYTIROGLOU, P
    EMRE, S
    BOCCAGNI, P
    CHODOFF, L
    SHEINER, P
    SCHWARTZ, M
    THUNG, SN
    MILLER, C
    [J]. TRANSPLANTATION, 1995, 59 (11) : 1631 - 1632
  • [6] FK-506 HEPATOTOXICITY IN LIVER ALLOGRAFT RECIPIENTS
    MOR, E
    BOCCAGNI, P
    SCHWARTZ, M
    THUNG, S
    HYTIROGLOU, P
    CHIODINI, S
    SHEINER, P
    EMRE, S
    MILLER, C
    [J]. HEPATOLOGY, 1993, 18 (04) : A75 - A75
  • [7] FK-506 USED AS RESCUE THERAPY FOR HUMAN LIVER ALLOGRAFT RECIPIENTS
    DEMETRIS, AJ
    FUNG, JJ
    TODO, S
    MCCAULEY, J
    JAIN, A
    TAKAYA, S
    ALESSIANI, M
    ABUELMAGD, K
    VANTHIEL, DH
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3005 - 3006
  • [8] COMPARISON OF THE IMMUNOSUPPRESSIVE AND TOXIC EFFECTS OF FK506 AND CYCLOSPORINE IN XENOGRAFT RECIPIENTS
    GUDAS, VM
    CARMICHAEL, PG
    MORRIS, RE
    [J]. TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1072 - 1073
  • [9] PROGNOSTIC FACTORS FOR SUCCESSFUL CONVERSION FROM CYCLOSPORINE TO FK-506 - BASED IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION
    KLINTMALM, GBG
    GOLDSTEIN, R
    GONWA, T
    WIESNER, RH
    KROM, RAF
    SHAW, BW
    STRATTA, R
    ASCHER, NL
    ROBERTS, JW
    LAKE, J
    BUSUTTIL, RW
    MCDIARMID, S
    ESQUIVEL, CO
    NAKAZATO, P
    MARSH, JW
    WOODLE, ES
    KALAYOGLU, M
    DALESSANDRO, AM
    PIRSCH, JD
    MILLER, C
    SCHWARTZ, M
    LEWIS, WD
    MONACO, AP
    JENKINS, RL
    EMOND, JC
    THISTLETHWAITE, JR
    WHITINGTON, PF
    STEINMULLER, DR
    FITZSIMMONS, WE
    LAWRENCE, I
    [J]. TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 641 - 643
  • [10] LONG-TERM EFFECTS OF FK506 FOLLOWING CONVERSION FROM CYCLOSPORINE TO FK506 FOR CHRONIC REJECTION IN LIVER-TRANSPLANT RECIPIENTS
    FUNG, JJ
    JAIN, A
    HAMMAD, I
    DOYLE, H
    SELBY, R
    TZAKIS, AG
    TODO, S
    STARZL, TE
    [J]. HEPATOLOGY, 1993, 18 (04) : A74 - A74
12345